Who is sponsoring NCT04059133?

NCT04059133 is sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital.

What drugs are being tested in NCT04059133?

Interventions in NCT04059133: DUOLITH SD1-TOP focused shock wave system (STORZ MEDICAL EvoTronTM, GA)-Sham arm, DUOLITH SD1-TOP focused shock wave system (STORZ MEDICAL EvoTronTM, GA)-LiESWT arm.

What condition does NCT04059133 study?

NCT04059133 studies Stress Urinary Incontinence, Overactive Bladder.

Is NCT04059133 still recruiting?

NCT04059133 is currently status unknown. Last updated 20 August 2019.

Last reviewed 2019-08-20 · How we verify

NCT04059133

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Low Intensity Extracorporeal Low Energy Shock Wave Therapy on Stress Urinary Incontinence and Overactivity Bladder

Status unknown NA Last updated 20 August 2019

What this trial tests

NA trial testing DUOLITH SD1-TOP focused shock wave system (STORZ MEDICAL EvoTronTM, GA)-Sham arm in Stress Urinary Incontinence in 180 participants. Status unknown.

Timeline

27 February 2018

Primary endpoint
31 July 2020

31 July 2020

Quick facts

Lead sponsor	Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	180
Start date	27 February 2018
Primary completion	31 July 2020
Estimated completion	31 July 2020
Sites	1 location across Taiwan

Drugs / interventions tested

DUOLITH SD1-TOP focused shock wave system (STORZ MEDICAL EvoTronTM, GA)-Sham arm
DUOLITH SD1-TOP focused shock wave system (STORZ MEDICAL EvoTronTM, GA)-LiESWT arm

Conditions studied

Stress Urinary Incontinence — all drugs for Stress Urinary Incontinence →
Overactive Bladder — all drugs for Overactive Bladder →

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital

Who can join

Adults 20 to 75, female only, with Stress Urinary Incontinence or Overactive Bladder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The hypothesis of the present study is low intensity extracorporeal low energy shock wave therapy (LiESWT) can decrease inflammatory disorders, increase pelvic floor blood supply, enhanced bladder stem cell activation, Using LiESWT can decrease bladder overactivity, eliminate urinary incontinence and improve stress urinary incontinence (SUI) and overactive bladder (OAB) symptoms. Therefore improve quality of life and improve social activity.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

Therapeutic effects of Low intensity extracorporeal low energy shock wave therapy (LiESWT) on stress urinary incontinence.
Long CY, Lin KL, Lee YC, Chuang SM, et al · · 2020 · cited 19× · PMID 32242035 · DOI 10.1038/s41598-020-62471-4
Low Intensity Extracorporeal Shock Wave Therapy as a Novel Treatment for Stress Urinary Incontinence: A Randomized-Controlled Clinical Study.
Lin KL, Chueh KS, Lu JH, Chuang SM, et al · · 2021 · cited 14× · PMID 34577869 · DOI 10.3390/medicina57090947
Low-Intensity Extracorporeal Shock Wave Therapy Promotes Bladder Regeneration and Improves Overactive Bladder Induced by Ovarian Hormone Deficiency from Rat Animal Model to Human Clinical Trial.
Lin KL, Lu JH, Chueh KS, Juan TJ, et al · · 2021 · cited 13× · PMID 34502202 · DOI 10.3390/ijms22179296
Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates the Overactive Bladder: A Prospective Pilot Study.
Lee YC, Chuang SM, Lin KL, Chen WC, et al · · 2020 · cited 13× · PMID 32724817 · DOI 10.1155/2020/9175676
Low Intensity Extracorporeal Shock Wave Therapy as a Potential Treatment for Overactive Bladder Syndrome.
Lu JH, Chueh KS, Chuang SM, Wu YH, et al · · 2021 · cited 9× · PMID 34208659 · DOI 10.3390/biology10060540
Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates Detrusor Hyperactivity with Impaired Contractility via Transient Potential Vanilloid Channels: A Rat Model for Ovarian Hormone Deficiency.
Chueh KS, Juan TJ, Lu JH, Wu BN, et al · · 2024 · cited 3× · PMID 38732143 · DOI 10.3390/ijms25094927
Microenergy shockwave therapies for female stress urinary incontinence.
Lin G, Lue TF. · · 2024 · cited 1× · PMID 39280672 · DOI 10.21037/tau-23-9

Verify or expand the search:

Other recruiting trials for Stress Urinary Incontinence

Currently open trials in the same condition.

NCT06706362 — Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study) · Phase 4 · recruiting
NCT06924450 — Effect of Modified Mesh on Surgical Success in Transobturator Tape Surgery · NA · recruiting
NCT06840093 — Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Randomized Controlled Trial · NA · recruiting
NCT06111209 — The Anabolic Effect of Testosterone on Pelvic Floor Muscles · Phase 2 · recruiting
NCT06731985 — The Follow-up After Shorter Tapes Study. Effectiveness and Safety of Shorter Trans-obturator Tapes. · recruiting

Other Kaohsiung Medical University Chung-Ho Memorial Hospital trials

Trials by the same sponsor.

NCT07342426 — High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis · Phase 4 · recruiting
NCT07346469 — Exploring the Effects of Magnesium Ions on Peripheral Neuropathy, Serum Magnesium Ion Concentration,Sleep Quality, and Q · NA · not yet recruiting
NCT07154407 — AI-assisted Masticatory Muscle Training in Patients With Schizophrenia · NA · not yet recruiting
NCT07154628 — Effect of Topical Lidocaine Spraying on the Vocal Cords Before Intubation During Robotic Surgery: a Randomized Controlle · Phase 4 · not yet recruiting
NCT07126444 — Effects of an Exercise Snack Intervention on Employee Health and Work Performance · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04059133 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kaohsiung Medical University Chung-Ho Memorial Hospital
Last refreshed: 20 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04059133.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing